The Delhi-based private laboratory, Dr Dangs Lab, has announced that they have been selected as the central laboratory for human clinical trials of Covaxin, which is touted as the first-ever indigenous vaccine developed by Bharat Biotech in collaboration with the Indian Council of Medical Research and National Institute of Virology, Pune. The human clinical trial ..
COVAXIN: GK, General Studies and Current Affairs
The Ethics Committee of the All India Institute of Medical Sciences (AIIMS) has given the approval to start the human trials for the indigenously developed COVID 19 vaccine, Covaxin. The premier hospital is expected to start the trial from July 20 on healthy volunteers. AIIMS New Delhi is one of the 12 sites designated by ..
On July 13, 2020, the AIIMS (All India Institute of Medical Sciences) Patna began human trials of COVID-19 on 10 volunteers. Highlights The first dose was given to selected 10 people though several volunteered. The second dose is to be given after interval of 14 days. A total of three doses of vaccine is to ..
On July 2, 2020, Indian Council of Medical Research announced that it is to launch COVAXIN, India’s first COVID-19 vaccine by August 15. Highlights There are 12 institutes that are conducting the clinical trials of the indigenous vaccine. Currently India has two indigenous manufacturers that are approved to conduct clinical trials for COVID-19 vaccine. They ..
The Drug Controller General of India approved to begin vaccine trial of Zydus Cadila. The firm is to conduct the vaccine trials in two phases. This is the second vaccine trial approved by India after Bharat Biotech’s COVAXIN. Highlights The DCGI approved the vaccine trials after the animal trials of the vaccine was satisfactory. The ..